HomeCompareCTIHY vs MRK

CTIHY vs MRK: Dividend Comparison 2026

CTIHY yields 1.61% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $31.2K in total portfolio value
10 years
CTIHY
CTIHY
● Live price
1.61%
Share price
$69.18
Annual div
$1.11
5Y div CAGR
16.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$928.59
Full CTIHY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CTIHY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTIHYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTIHY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTIHY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTIHY
Annual income on $10K today (after 15% tax)
$136.95/yr
After 10yr DRIP, annual income (after tax)
$789.30/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,539.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTIHY + MRK for your $10,000?

CTIHY: 50%MRK: 50%
100% MRK50/50100% CTIHY
Portfolio after 10yr
$41.2K
Annual income
$5,363.37/yr
Blended yield
13.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CTIHY
No analyst data
Altman Z
0.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTIHY buys
0
MRK buys
0
No recent congressional trades found for CTIHY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTIHYMRK
Forward yield1.61%2.76%
Annual dividend / share$1.11$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR16.5%32.7%
Portfolio after 10y$25.5K$56.8K
Annual income after 10y$928.59$9,798.13
Total dividends collected$4.7K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CTIHY vs MRK ($10,000, DRIP)

YearCTIHY PortfolioCTIHY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,888$187.71$11,206$366.19$318.00MRK
2$11,872$222.51$12,650$502.35$778.00MRK
3$12,968$264.18$14,407$694.19$1.4KMRK
4$14,190$314.17$16,585$967.82$2.4KMRK
5$15,557$374.29$19,342$1,363.89$3.8KMRK
6$17,093$446.80$22,913$1,947.19$5.8KMRK
7$18,824$534.49$27,662$2,823.89$8.8KMRK
8$20,782$640.88$34,159$4,173.35$13.4KMRK
9$23,008$770.39$43,337$6,308.80$20.3KMRK
10$25,547$928.59$56,776$9,798.13$31.2KMRK

CTIHY vs MRK: Complete Analysis 2026

CTIHYStock

China Taiping Insurance Holdings Company Limited, an investment holding company, underwrites various insurance and reinsurance products in the People's Republic of China and internationally. The company operates through three business segments: Life Insurance, Property and Casualty Insurance, and Reinsurance. The Life Insurance segment provides life insurance products, such as individual and group life insurance, health insurance, and accident insurance products and annuities. The Property and Casualty Insurance segment offers compulsory motor insurance, liability insurance, credit insurance, guarantee insurance, and short-term accident and health insurance, as well as the related reinsurance products. The Reinsurance segment provides property damage, life, marine cargo and hull, and miscellaneous non-marine reinsurance products. The company also engages in the assets management, insurance intermediary, financial leasing, property investment, and securities dealing and broking, as well as in elderly care investment businesses; and manages investment funds. In addition, it provides corporate and personal retirement insurance products; and back-to-back financing arrangement, as well as insurance broking and agency services. The company was formerly known as China Insurance International Holdings Company Limited and changed its name to China Taiping Insurance Holdings Company Limited in August 2009. The company was incorporated in 2000 and is headquartered in North Point, Hong Kong. China Taiping Insurance Holdings Company Limited is a subsidiary of China Taiping Insurance Group (HK) Company Limited.

Full CTIHY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CTIHY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTIHY vs SCHDCTIHY vs JEPICTIHY vs OCTIHY vs KOCTIHY vs MAINCTIHY vs JNJCTIHY vs ABBVCTIHY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.